Radiation following chemotherapy for mediastinal Hodgkin's disease: the outcome of various doses for bulky tumors

被引：3
作者：
Eisbruch, A
Kazerooni, EA
Sahijdak, WM
Francis, IR
Lichter, AS
机构：
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA
来源：
RADIOTHERAPY AND ONCOLOGY | 1998年 / 46卷 / 01期
关键词：
radiation; chemotherapy; Hodgkin's disease; bulky tumors;
D O I：
10.1016/S0167-8140(97)00161-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Twenty-one patients with bulky mediastinal disease responding to chemotherapy received consolidation with low-dose mediastinal radiation (19.8-25.2 Gy). Their 5-year mediastinal failure rate (10%) was equivalent to that of 10 similar patients who received higher doses of 30-44 Gy (20%). Low-dose radiation may be appropriate for these patients. Prospective studies are required to verify these findings. (C) 1998 Elsevier Science Ireland Ltd.
引用
收藏
页码：47 / 49
页数：3
相关论文
共 50 条
  • [21] Mediastinal bulky tumour in Hodgkin's disease and prognostic value of positron emission tomography in the evaluation of post-treatment residual masses
    Keresztes, K
    Lengyel, Z
    Devenyi, K
    Vadasz, G
    Miltenyi, Z
    Illes, A
    ACTA HAEMATOLOGICA, 2004, 112 (04) : 194 - 199
  • [22] BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease
    Diehl, V
    Sieber, M
    Ruffer, U
    Lathan, B
    Hasenclever, D
    Pfreundschuh, M
    Loeffler, M
    Lieberz, D
    Koch, P
    Adler, M
    Tesch, H
    ANNALS OF ONCOLOGY, 1997, 8 (02) : 143 - 148
  • [23] Intensified ABVP chemotherapy for the primary treatment of Hodgkin's disease
    Spector, N
    Costa, MA
    Morais, JC
    Biasoli, I
    Solza, C
    Gaui, MD
    Ferreira, CG
    Portugal, RD
    Loureiro, M
    Nucci, M
    Pulcheri, W
    ONCOLOGY REPORTS, 2002, 9 (02) : 439 - 442
  • [24] Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy
    Reddy, AT
    Janss, AJ
    Phillips, PC
    Weiss, HL
    Packer, RJ
    CANCER, 2000, 88 (09) : 2189 - 2193
  • [25] Cardiac risk after mediastinal irradiation for Hodgkin's disease
    Glanzmann, C
    Kaufmann, P
    Jenni, R
    Hess, OM
    Huguenin, P
    RADIOTHERAPY AND ONCOLOGY, 1998, 46 (01) : 51 - 62
  • [26] Bronchial erosion of mediastinal lymphadenopathy associated with Hodgkin's disease
    Brinchault, G
    Rochefort-Morel, C
    Morel, V
    Edan, C
    Caulet-Maugendre, S
    Lena, H
    Delaval, P
    REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (01) : 137 - 140
  • [27] Augmented therapy of extensive Hodgkin's disease: Radiation to known disease or prolongation of induction chemotherapy did not improve survival - Results of a cancer and leukemia group B study
    Coleman, M
    Rafla, S
    Propert, KJ
    Glicksman, A
    Peterson, B
    Nissen, N
    Brunner, K
    Holland, JF
    Anderson, JR
    Gottlieb, A
    Kaufman, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (03): : 639 - 645
  • [28] BULKY MEDIASTINAL HODGKINS-DISEASE - RESULTS OF A COMBINED-MODALITY APPROACH (ABVD MOPP ALTERNATING CHEMOTHERAPY PLUS RADIATION-THERAPY)
    DELENA, M
    DITONNO, P
    LORUSSO, V
    TIMURIAN, A
    PELLECCHIA, A
    BRANDI, M
    BERARDI, F
    MARZULLO, F
    HAEMATOLOGICA, 1993, 78 (04) : 230 - 235
  • [29] Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy
    Elconin, JH
    Roberts, KB
    Rizzieri, DA
    Vermont, C
    Clough, RW
    Kim, C
    Dodge, RK
    Prosnitz, LR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (04): : 1097 - 1105
  • [30] The evolving role of radiation therapy in pediatric Hodgkin's disease
    Fredman, Elisha
    Mansur, David B.
    Russo, Suzanne
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (06) : 605 - 613
12345